RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (R-Int)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The primary objective of the RESOLUTE international registry is to document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a 'real-world' patient population requiring stent implantation.
Condition or disease
Coronary Artery DiseaseCardiovascular Diseases
Device: Endeavor Resolute Zotarolimus-Eluting Coronary Stent System
As part of the broader clinical program of the Resolute stent, the RESOLUTE International registry will expand the experience and understanding of the device performance in a 'real-world' setting. The registry intends to enroll patients from a large number of centers under commercial usage conditions, with the aim to reflect 'real-world' usage as much as possible.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All consecutive patients eligible for drug-eluting stent implantation with the elective use of the Endeavor Resolute stent in one or more target lesions are candidates to be enrolled
Minimum legal age (18)
Acceptable candidate for treatment with a drug-eluting stent in accordance with applicable guidelines
Patient has consented to participate and authorized in writing the collection and release of medical information
Elective use of the Endeavor Resolute stent
High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
Currently participating in another trial preventing routine hospital treatment
Previous enrollment in the RESOLUTE International registry